Recurrence: all 3,523 studies
Page 29 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate CancerCompletedNCT01804231Not applicable
- Crystallized Phenol Versus Transposition Flaps for Treatment of Pilonidal Disease: A Prospective StudyStatus unknownNCT01792557Not applicable
- Moxonidine for Prevention of Post-ablation AFib RecurrencesCompletedNCT01791699Phase 4
- Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell LymphomasCompletedNCT01788189Phase 1/2
- Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)WithdrawnNCT01782976Phase 2
- A Dose Escalation Study of OMP-52M51 in Subjects With Solid TumorsCompletedNCT01778439Phase 1
- Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma PatientsCompletedNCT01776411Phase 1/2
- Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)CompletedNCT01774630Phase 2
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung CancerTerminatedNCT01774578Phase 2/3
- Algorithm Guided Treatment Strategies for Major Depressive DisorderStatus unknownNCT01764867Phase 4
- Post-approval Study of NovoTTF-100A in Recurrent GBM PatientsTerminatedNCT01756729Phase 4
- MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaCompletedNCT01748721Phase 1
- Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant GliomasCompletedNCT01748149Early Phase 1
- Long-term Anastrozole Versus Tamoxifen Treatment EffectsCompletedNCT01745289
- Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or ProgressiveCompletedNCT01737450Phase 2
- Procarbazine and Lomustine in Recurrent GlioblastomaStatus unknownNCT01737346Phase 2
- Artemisinin-resistant Malaria in CambodiaCompletedNCT01736319
- Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell LymphomaTerminatedNCT01729104Phase 1
- The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis CohortCompletedNCT01723709
- Circulating miRNAs.CompletedNCT01722851
- Cortical Excitability and Inhibition in MDDCompletedNCT01718730
- Hepatocellular Carcinoma Treated With Iodine-125 ImplantationCompletedNCT01717729Phase 3
- Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD RecurrenceCompletedNCT01714050Not applicable
- Pazopanib in Relapsed and Refractory Small Cell Lung CancerCompletedNCT01713296Phase 2
- Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular CarcinomaStatus unknownNCT01713244Not applicable
- Degarelix in the Treatment of Endometriosis RecurrenceCompletedNCT01712763Phase 3
- Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer PatientsStatus unknownNCT01710085Not applicable
- GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary TherapyCompletedNCT01704274Phase 2
- A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid MalignanciesCompletedNCT01703572Phase 1
- PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced MalignancyCompletedNCT01696565Phase 1/2
- The Immunoscore as a Prognostic Marker for Patients With a Colorectal CancerStatus unknownNCT01688232
- Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed MyelomaStatus unknownNCT01686386Phase 1/2
- Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid TumorCompletedNCT01684098Phase 2
- Sorafenib and Topotecan in Refractory/Recurrent Pediatric MalignanciesCompletedNCT01683149Phase 1
- Lenalidomide Plus Chemotherapy for AMLCompletedNCT01681537Phase 1
- 131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell LymphomaStatus unknownNCT01678417Phase 2
- 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell LymphomaStatus unknownNCT01678404Phase 2
- A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)Status unknownNCT01676558Phase 2
- Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)Status unknownNCT01675219Phase 3
- Risk Factors Associated With Recurrence and Life-threatening Complications for CSOJCompletedNCT01670422
- Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid TumorsCompletedNCT01670175Phase 1
- Risk Factors for Poor Outcome After Epigastric and Umbilical Hernia RepairCompletedNCT01665859
- AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute LeukemiaTerminatedNCT01655875Phase 1
- Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian CancerStatus unknownNCT01650376Phase 1/2
- Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)WithdrawnNCT01649622Phase 2
- Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaCompletedNCT01647971Phase 1/2
- Recurrent and Nonrecurrent Condyloma TreatmentTerminatedNCT01639638Phase 2/3
- Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple MyelomaApproved for marketingNCT01632826
- Smoking Relapse-Prevention Intervention for Cancer PatientsCompletedNCT01630161Not applicable
- Contact Force Sensing and Pulmonary Vein IsolationStatus unknownNCT01630031
- Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active ControlCompletedNCT01626248
- Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced CancersCompletedNCT01624766Phase 1
- To Scan or Not to Scan: The Role of Follow-up CT Scanning for Management of Chronic Subdural Hematoma After Neurosurgical EvacuationCompletedNCT01624545Not applicable
- Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian CancerCompletedNCT01623349Phase 1
- Multiple Antigen-Engineered DC Vaccine for MelanomaCompletedNCT01622933Phase 1
- PF-03446962 in Relapsed or Refractory Urothelial CancerCompletedNCT01620970Phase 2
- A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and TaxanesCompletedNCT01620242Phase 2
- Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLLTerminatedNCT01612988Phase 2
- Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?Status unknownNCT01611766Phase 3
- Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian CancerCompletedNCT01610869Phase 2
- Effect of Reoperation for Recurrence After Open Umbilical Hernia RepairCompletedNCT01607801
- Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell LymphomaCompletedNCT01606605
- A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.TerminatedNCT01606566Phase 2
- Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh FixationCompletedNCT01597011
- Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in ChildrenStatus unknownNCT01593488Phase 2
- IPHC in Patients With Platinum-sensitive Recurrent Ovarian CancerCompletedNCT01588964Phase 2
- Videoendoscopic Pilonidal Sinus SurgeryStatus unknownNCT01583751Phase 1
- Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple MyelomaCompletedNCT01583283Phase 1
- Vorinostat Plus FND in Relapsed or Refractory Mantle Cell LymphomaTerminatedNCT01578343Phase 2
- A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01572519Phase 1
- Deep Brain Stimulation of Nucleus Accumbens for Chronic and Resistant Major Depressive DisorderCompletedNCT01569711
- Evaluating the Effectiveness of a Chronic Disease Management Program for GoutCompletedNCT01568879Not applicable
- Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple MyelomaActive, not recruitingNCT01562405Phase 1
- A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent GlioblastomaCompletedNCT01562197Phase 2
- The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian CancerCompletedNCT01556841Phase 2
- Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed MalignanciesTerminatedNCT01553071Phase 1
- Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid TumorsCompletedNCT01544322Phase 1
- Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular LymphomaCompletedNCT01542918Phase 1
- Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer RecurrenceStatus unknownNCT01539785Not applicable
- Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral TherapyCompletedNCT01539005
- Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF MutationsCompletedNCT01531361Phase 1
- Metformin in Children With Relapsed or Refractory Solid TumorsCompletedNCT01528046Phase 1
- Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MMCompletedNCT01526694Phase 2
- Optic Neuritis Recovery After Oral or IV CorticosteroidsCompletedNCT01524250Phase 2/3
- Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALLCompletedNCT01523977Phase 1
- Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic SyndromeWithdrawnNCT01520805Phase 2
- BiPAP-Vapotherm RCTWithdrawnNCT01518140Phase 2
- Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsTerminatedNCT01517776Phase 2
- Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After TransplantationTerminatedNCT01517347Not applicable
- Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of DepressionCompletedNCT01516931Not applicable
- Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone LymphomaCompletedNCT01516606Phase 2
- Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01515969Phase 1
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaCompletedNCT01498328Phase 2
- Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaCompletedNCT01497093Phase 1
- Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has ReturnedCompletedNCT01495663Phase 1
- A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal CancerCompletedNCT01493206Phase 2
- Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast CancerStatus unknownNCT01492556Phase 2
- Major RF Ablations of Hepatomas Under MR Thermometry MonitoringTerminatedNCT01486134Not applicable
- Risk Factors for Morbidity After Parastomal Hernia RepairCompletedNCT01484743
- A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian CarcinomaCompletedNCT01481701Phase 2